215 related articles for article (PubMed ID: 16008344)
21. Concentration-dependent roles for heparin in modifying lipopolysaccharide-induced activation of mononuclear cells in whole blood.
Hochart H; Jenkins PV; Preston RJ; Smith OP; White B; O'Donnell J
Thromb Haemost; 2008 Mar; 99(3):570-5. PubMed ID: 18327406
[TBL] [Abstract][Full Text] [Related]
22. A comparison of equine and bovine sera as sources of lipopolysaccharide-binding protein activity in equine monocytes incubated with lipopolysaccharide.
Figueiredo MD; Salter CE; Hurley DJ; Moore JN
Vet Immunol Immunopathol; 2008 Feb; 121(3-4):275-80. PubMed ID: 18023485
[TBL] [Abstract][Full Text] [Related]
23. LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells.
Blais DR; Vascotto SG; Griffith M; Altosaar I
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4235-44. PubMed ID: 16249503
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of aldose reductase prevents lipopolysaccharide-induced inflammatory response in human lens epithelial cells.
Pladzyk A; Reddy AB; Yadav UC; Tammali R; Ramana KV; Srivastava SK
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5395-403. PubMed ID: 17122129
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of inflammatory response in human keratinocytes by magnetic nanoparticles functionalized with PBP10 peptide derived from the PIP2-binding site of human plasma gelsolin.
Piktel E; Wnorowska U; Cieśluk M; Deptula P; Pogoda K; Misztalewska-Turkowicz I; Paprocka P; Niemirowicz-Laskowska K; Wilczewska AZ; Janmey PA; Bucki R
J Nanobiotechnology; 2019 Feb; 17(1):22. PubMed ID: 30711007
[TBL] [Abstract][Full Text] [Related]
26. Lipopolysaccharide-binding protein down-regulates the expression of interleukin-6 by human gingival fibroblast.
Ren L; Leung WK; Loo TW; Jin L
J Periodontal Res; 2005 Oct; 40(5):407-16. PubMed ID: 16105094
[TBL] [Abstract][Full Text] [Related]
27. Neisseria meningitidis type C capsular polysaccharide inhibits lipooligosaccharide-induced cell activation by binding to CD14.
Kocabas C; Katsenelson N; Kanswal S; Kennedy MN; Cui X; Blake MS; Segal DM; Akkoyunlu M
Cell Microbiol; 2007 May; 9(5):1297-310. PubMed ID: 17250593
[TBL] [Abstract][Full Text] [Related]
28. Lipopolysaccharide recognition protein, MD-2, facilitates cellular uptake of E. coli-derived plasmid DNA in synovium.
Kolka JA; Vreede AP; Roessler BJ
J Gene Med; 2005 Jul; 7(7):956-64. PubMed ID: 15772934
[TBL] [Abstract][Full Text] [Related]
29. Endotoxin interactions with lipopolysaccharide-responsive cells.
Tobias PS; Tapping RI; Gegner JA
Clin Infect Dis; 1999 Mar; 28(3):476-81. PubMed ID: 10194064
[TBL] [Abstract][Full Text] [Related]
30. Activation of the adenosine A3 receptor in RAW 264.7 cells inhibits lipopolysaccharide-stimulated tumor necrosis factor-alpha release by reducing calcium-dependent activation of nuclear factor-kappaB and extracellular signal-regulated kinase 1/2.
Martin L; Pingle SC; Hallam DM; Rybak LP; Ramkumar V
J Pharmacol Exp Ther; 2006 Jan; 316(1):71-8. PubMed ID: 16188954
[TBL] [Abstract][Full Text] [Related]
31. Thymulin and zinc (Zn2+)-mediated inhibition of endotoxin-induced production of proinflammatory cytokines and NF-kappaB nuclear translocation and activation in the alveolar epithelium: unraveling the molecular immunomodulatory, anti-inflammatory effect of thymulin/Zn2+ in vitro.
Haddad JJ
Mol Immunol; 2009 Dec; 47(2-3):205-14. PubMed ID: 19850345
[TBL] [Abstract][Full Text] [Related]
32. Heat shock protein 60: specific binding of lipopolysaccharide.
Habich C; Kempe K; van der Zee R; Rümenapf R; Akiyama H; Kolb H; Burkart V
J Immunol; 2005 Feb; 174(3):1298-305. PubMed ID: 15661886
[TBL] [Abstract][Full Text] [Related]
33. A novel TLR4-binding peptide that inhibits LPS-induced activation of NF-kappaB and in vivo toxicity.
Sugiyama K; Muroi M; Tanamoto K
Eur J Pharmacol; 2008 Oct; 594(1-3):152-6. PubMed ID: 18700140
[TBL] [Abstract][Full Text] [Related]
34. Lipopolysaccharide activates NF-kappaB by TLR4-Bcl10-dependent and independent pathways in colonic epithelial cells.
Bhattacharyya S; Dudeja PK; Tobacman JK
Am J Physiol Gastrointest Liver Physiol; 2008 Oct; 295(4):G784-90. PubMed ID: 18718996
[TBL] [Abstract][Full Text] [Related]
35. Glucose phosphorylated on carbon 6 suppresses lipopolysaccharide binding to lipopolysaccharide-binding protein and inhibits its bioactivities.
Fujita Y; Yagi K
Int Immunopharmacol; 2017 Apr; 45():43-52. PubMed ID: 28187312
[TBL] [Abstract][Full Text] [Related]
36. Protein fusions of BPI with CETP retain functions inherent to each.
Lloyd DB; Bonnette P; Thompson JF
Biochemistry; 2006 Oct; 45(43):12954-9. PubMed ID: 17059212
[TBL] [Abstract][Full Text] [Related]
37. Lipopolysaccharide neutralization by the antibacterial peptide CM4.
Lin QP; Zhou LF; Li NN; Chen YQ; Li BC; Cai YF; Zhang SQ
Eur J Pharmacol; 2008 Oct; 596(1-3):160-5. PubMed ID: 18789317
[TBL] [Abstract][Full Text] [Related]
38. Involvement of MAPKs and NF-kappaB in LPS-induced VCAM-1 expression in human tracheal smooth muscle cells.
Lin WN; Luo SF; Lee CW; Wang CC; Wang JS; Yang CM
Cell Signal; 2007 Jun; 19(6):1258-67. PubMed ID: 17303384
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP
J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270
[TBL] [Abstract][Full Text] [Related]
40. Bacterial endotoxin as inhibitor of the enzymatic activity of human thrombin.
Bucki R; Pastore JJ
Eur J Haematol; 2006 Jun; 76(6):510-5. PubMed ID: 16529602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
